THE LATEST WORD

Top Industry Stories – April 30, 2010

Posted on April 30th, 2010 | by Rxmedyn | No Comments »

Study Sharpens Focus on Glaxo’s Heart Drug Hope

Promise Seen in Drug for Retardation Syndrome

FDA Approves $93K Prostate Cancer Vaccine

ACCME Plan For Limited Transparency Draws Support

MDiTV To Feature Medical News, Live Surgeries

Posted in Industry Stories

Top Industry Stories – April 29, 2010

Posted on April 29th, 2010 | by Rxmedyn | No Comments »

Sanofi-Aventis 1st Quarter Profit Up 8.6 Percent

2 J&J Subsidiaries Agree to Settle on Topamax

Glaxo’s Sales, Profit Increase

Bristol-Myers’ Profit Rises, but Outlook Slips on Reform Costs

Posted in Industry Stories

Top Industry Stories – April 28, 2010

Posted on April 28th, 2010 | by Rxmedyn | No Comments »

Americans Losing Confidence in Healthcare

Medco 1Q Profit Up 10 Percent on New Client Wins

Cosmetic Surgeries Get a Little Nip and Tuck

Pfizer Pushes on New Biotech Drugs

Next in Health Care War: Applying The Law

Read the rest of this entry »

Posted in Industry Stories

Top Industry Stories – April 27, 2010

Posted on April 27th, 2010 | by Rxmedyn | No Comments »

U.S. Spending on Plastic Surgery Dips to $10 Billion

Novo Nordisk Lifts 2010 Revenue, Profit Forecasts

The Search for Genes Leads to Unexpected Places

Educational Program Urges Parents to Immunize Kids

California Agency Posts RFP For Healthy Living Campaign

Posted in Industry Stories

Top Industry Stories – April 23, 2010

Posted on April 23rd, 2010 | by Rxmedyn | No Comments »

Spanish Hospital Claims 1st Full-Face Transplant

Astellas Extends Offer Deadline for OSI a Second Time

An Unforeseen Complication of Electronic Medical Records

CBO: 4 Million Americans To Be Hit By Insurance Penalties in 2016

Merck Gets Split Patent Decision; Vytorin Copay Raised

Read the rest of this entry »

Posted in Industry Stories

Top Industry Stories – April 22, 2010

Posted on April 22nd, 2010 | by Rxmedyn | No Comments »

Pre-Term Babies Face Lifelong Lung Trouble

Biggest Study on Cellphone Health Effects Launched

‘Dead as Doornail’ Gene Therapy Revival Spurs Genzyme

Baxter Falls After Forecast Cut on Health-Care Costs

Can Botox Stop the Hands From Shaking?

Read the rest of this entry »

Posted in Industry Stories

Top Industry Stories – April 21, 2010

Posted on April 21st, 2010 | by Rxmedyn | No Comments »

Colin Powell and Bill Gates Join Malaria Campaign

Merck Inks Deal on Tetanus, Diphtheria Vaccine

Abbott First-Quarter Profit Falls as Costs Increase

Senate Bill Sets a Plan to Regulate Premiums

Drug Maker Elan Narrows Loss

Read the rest of this entry »

Posted in Uncategorized

Top Industry Stories – April 20, 2010

Posted on April 20th, 2010 | by Rxmedyn | No Comments »

Changing Old Habits Could Save Big On Drug Costs

Biogen First-Quarter Profit Drops on Higher Research

J&J First-Quarter Profit Rises on Device Sales Gains

Benefit for Uninsured May Still Pose Hurdle

Cancer Fight: Unclear Tests for New Drug

Read the rest of this entry »

Posted in Uncategorized

Top Industry Stories – April 19, 2010

Posted on April 19th, 2010 | by Rxmedyn | No Comments »

Pfizer, Impax Switch Co-Promotion Duties From Pristiq to Lyrica

US FDA Must Test New Drugs Against Current Therapies, Not Placebo

Obama Health Team Turns to Carrying Out Law

Doctors Hear Many Questions About Health Law

FDA Weighs Halting Avandia Safety Study

Read the rest of this entry »

Posted in Industry Stories

Top Industry Stories – April 16, 2010

Posted on April 16th, 2010 | by Rxmedyn | No Comments »

Cancer Research by U.S. Disorganized, Underfunded, Study Says

Obama Extends Health Care rights To Gay Partners

Genzyme Drug Shortage Leaves Users Feeling Betrayed

FDA Steps Up Enforcement of Generics Firm

Apple’s Tablet Tempts Mobile CME App Makers

Posted in Industry Stories

Older Posts